Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Report

Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report By Drug Type (Stimulant, Non-stimulant), By Demographic, By Distribution Channel (Hospital & Retail Pharmacy), And Segment Forecasts, 2019 - 2025

  • Report ID: GVR-2-68038-795-7
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2018
  • Industry: Healthcare

Table of Content

Chapter 1 Executive Summary
                   1.1 Market Snapshot
Chapter 2 Market Definitions
                   2.1 Objective
Chapter 3 Research Methodology
                   3.1 Information Procurement
                   3.2 Data Analysis
Chapter 4 Market Variables, Trends, & Scope
                   4.1 Market Segmentation and Scope
                       4.1.1 Market driver analysis
                           4.1.1.1 Increasing prevalence of ADHD
                           4.1.1.2 Increasing awareness regarding ADHD among physicians and patients
                       4.1.2 Market restraint analysis
                           4.1.2.1 Less availability of non-stimulants ADHD drugs
                           4.1.2.2 Underdiagnosis of ADHD
                   4.2 Penetration & Growth Prospects Mapping
                   4.3 Attention deficit hyperactivity disorder (ADHD) Market - PESTLE Analysis
                   4.4 Industry Analysis - Porter’s
                   4.5 Attention deficit hyperactivity disorder (ADHD) Competitive Landscape: Market Position Analysis (Based on Services, Regional Presence, and Recent Updates)
Chapter 5 Attention Deficit Hyperactivity Disorder (ADHD) Market: Drug Estimates & Trend Analysis
                   5.1 Amphetamine
                       5.1.2 Amphetamines market, 2014 - 2025 (USD Million)
                   5.2 Methylphenidate
                       5.2.1 Methylphenidate market, 2014 - 2025 (USD Million)
                   5.3 Lisdexamfetamine
                       5.3.1 Lisdexamfetamine market, 2014 - 2025 (USD Million)
                   5.4 Dexmethylphenidate
                       5.4.1 Dexmethylphenidate market, 2014 - 2025 (USD Million)
                   5.5 Atomoxetine
                       5.5.1 Atomoxetine market, 2014 - 2025 (USD Million)
                   5.6 Guanfacine
                       5.6.1 Guanfacine market, 2014 - 2025 (USD Million)
                   5.7 Clonidine
                       5.7.1 Clonidine market, 2014 - 2025 (USD Million)
                   5.8 Bupropion
                       5.8.1 Bupropion market, 2014 - 2025 (USD Million)
Chapter 6 Attention Deficit Hyperactivity Disorder (ADHD) Market: Drug Type Estimates & Trend Analysis
                   6.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Drug Type Analysis
                   6.2 Stimulants
                       6.2.1. Stimulants market, 2014 - 2026 (USD Million)
                   6.3 Non-Stimulants
                       6.3.1 Non-stimulants market, 2014 - 2026 (USD Million)
Chapter 7 Attention Deficit Hyperactivity Disorder (ADHD) Market: Demographic Estimates & Trend Analysis
                   7.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: By Age Analysis
                       7.1.1 Children (2-17 years of age)
                           7.1.1.1 Children (2-17 years of age) market, 2014 - 2025 (USD Million)
                       7.1.2 Adults
                           7.1.2.1 Adults market, 2014 - 2025 (USD Million)
Chapter 8 Attention Deficit Hyperactivity Disorder (ADHD) Market: Distribution Channel Estimates & Trend Analysis
                   8.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Distribution Channel Analysis
                   8.2 Hospital Pharmacy
                       8.2.1 Hospital Pharmacy market, 2014 - 2025 (USD Million)
                   8.3 Retail Pharmacy
                       8.3.1 Retail Pharmacy market, 2014 - 2025 (USD Million)
Chapter 9 Attention deficit hyperactivity disorder (ADHD) Market : Regional Estimates & Trend Analysis
                   9.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Share, By Region, 2014 & 2025
                   9.2 North America
                       9.2.1 US
                           9.2.1.1 U.S. attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.2.2 Canada
                           9.2.2.1 Canada attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD million )
                   9.3 Europe
                       9.3.1 Europe attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.2 U.K.
                           9.3.2.1 U.K. attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.3 Germany
                           9.3.3.1 Germany attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.3.4 France
                           9.3.4.1 Germany attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.4 Asia Pacific
                       9.4.1 Asia Pacific attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.4.2 Japan
                           9.4.2.1 Japan Attention deficit hyperactivity disorder (ADHD) Market, 2014 - 2025 (USD Million)
                       9.4.3 China
                           9.4.3.1 China attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.5 Latin America
                       9.5.1 Latin America attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.5.2 Brazil
                           9.5.2.1 Brazil attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.5.3 Mexico
                           9.5.3.1 Mexico attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                   9.6 MEA
                       9.6.1 MEA attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
                       9.6.2 South Africa
                           9.6.2.1 South Africa attention deficit hyperactivity disorder (ADHD) market, 2014 - 2025 (USD Million)
Chapter 10 Competitive Landscape
                   10.1 Strategy Framework
                   10.2 Company Profiles
                       10.2.1 Eli Lily & Company
                           10.2.1.1 Company overview
                           10.2.1.2 Financial performance
                           10.2.1.3 Product benchmarking
                           10.2.1.4 Strategic initiatives
                       10.2.2 Novartis AG
                           10.2.2.1 Company overview
                           10.2.2.2 Financial performance
                           10.2.2.3 Product benchmarking
                           10.2.2.4 Strategic initiatives
                       10.2.3 Pfizer
                           10.2.3.1 Company overview
                           10.2.3.2 Financial performance
                           10.2.3.3 Product benchmarking
                           10.2.3.4 Strategic initiatives
                       10.2.4 Johnson & Johnson Services, LLC
                           10.2.4.1 . Company overview
                           10.2.4.2 Financial performance
                           10.2.4.3 Product benchmarking
                           10.2.4.4 Strategic initiatives
                       10.2.5 Lupin
                           10.2.5.1 Company overview
                           10.2.5.1 Financial performance
                           10.2.5.2 Product benchmarking
                           10.2.5.3 Strategic initiatives
                       10.2.6 Shire
                           10.2.6.1 Company overview
                           10.2.6.2 Financial performance
                           10.2.6.3 Product benchmarking
                           10.2.6.4 Strategic initiatives
                       10.2.7 Mallinckrodt
                           10.2.7.1 Company overview
                           10.2.7.2 Financial performance
                           10.2.7.3 Product benchmarking
                           10.2.7.4 Strategic initiatives
                       10.2.8 Prude Pharma L.P.
                           10.2.8.1 Company overview
                           10.2.8.2 Financial performance
                           10.2.8.3 Product benchmarking
                           10.2.8.4 Strategic initiatives
                       10.2.9 NEOS Therapeutics Inc.
                           10.2.9.1 Company overview
                           10.2.9.2 Financial performance
                           10.2.9.3 Product benchmarking
                           10.2.9.4 Strategic initiatives


List of Tables

TABLE 1 FDA-Approved ADHD Medication
TABLE 2 Non-stimulants medications used for ADHD
TABLE 3 ADHD stimulants retail prices in the U.S., 2012
TABLE 4 North America ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 5 North America ADHD, by drug type, 2014 - 2025 (USD Million)
TABLE 6 North America ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 7 North America ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 8 U.S. ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 9 U.S. ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 10 U.S. ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 11 Canada ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 12 Canada ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 13 Canada ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 14 Europe ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 15 Europe ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 16 Europe ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 17 Europe ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 18 U.K. ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 19 U.K. ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 20 U.K. ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 21 Germany ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 22 Germany ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 23 Germany ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 24 France ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 25 France ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 26 France ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 30 Asia Pacific ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 31 Japan ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 32 Japan ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 33 Japan ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 34 China ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 35 China ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 36 China ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 37 Latin America ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 38 Latin America ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 39 Latin America ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 40 Latin America ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 41 Brazil ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 42 Brazil ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 43 Brazil ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 44 Mexico ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 45 Mexico ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 46 Mexico ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 47 MEA ADHD market, by country, 2014 - 2025 (USD Million)
TABLE 48 MEA ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 49 MEA ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 50 MEA ADHD market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 51 South Africa ADHD market, by drug type, 2014 - 2025 (USD Million)
TABLE 52 South Africa ADHD market, by demographics, 2014 - 2025 (USD Million)
TABLE 53 South Africa ADHD market, by distribution channel, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market summary 2018, (USD million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Attention deficit hyperactivity disorder (ADHD) market - PESTLE analysis
FIG. 14 Porter’s five forces analysis
FIG. 15 Attention deficit hyperactivity disorder (ADHD) competitive landscape: Market position analysis (based on product portfolio, regional presence, and strategic initiatives)
FIG. 16 Amphetamines market, 2014 - 2025 (USD Million)
FIG. 17 Methylphenidate market, 2014 - 2025 (USD Million)
FIG. 18 Lisdexamfetamine market, 2014 - 2025 (USD Million)
FIG. 19 Dexmethylphenidate market, 2014- 2025 (USD Million)
FIG. 20 Atomoxetine market, 2014 - 2025 (USD Million)
FIG. 21 Guanfacine market, 2014 - 2025 (USD Million)
FIG. 22 Clonidine market, 2014 - 2025 (USD Million)
FIG. 23 Bupropion market, 2014 - 2025 (USD Million)
FIG. 24 Attention deficit hyperactivity disorder (ADHD) market, drug type outlook: Key takeaways
FIG. 25 Attention deficit hyperactivity disorder (ADHD) market: drug type movement analysis
FIG. 26 Stimulants market, 2014 - 2025 (USD Million)
FIG. 27 Non-stimulants market, 2014 - 2025 (USD Million)
FIG. 28 Attention deficit hyperactivity disorder (ADHD) market, Demographic outlook: Key takeaways
FIG. 29 Attention deficit hyperactivity disorder (ADHD) Market: By demographic movement analysis
FIG. 30 Children (2-17 years of age) ADHD market, 2014 - 2025 (USD Million)
FIG. 31 Adults ADHD market, 2014 - 2025 (USD Million)
FIG. 32 Attention deficit hyperactivity disorder (ADHD) market, Distribution channel outlook: Key takeaways
FIG. 33 Attention deficit hyperactivity disorder (ADHD) market: Distribution channel movement analysis
FIG. 34 Hospital pharmacy market, 2014 - 2025 (USD Million)
FIG. 35 Retail pharmacy market, 2014 - 2025 (USD Million)
FIG. 36 Regional market place: Key takeaways
FIG. 37 Attention deficit hyperactivity disorder (ADHD) Market: Regional outlook, 2014 & 2025
FIG. 38 North America ADHD market, 2014 - 2025 (USD Million)
FIG. 39 U.S. ADHD market, 2014 - 2025 (USD Million)
FIG. 40 Canada ADHD market, 2014 - 2025 (USD million )
FIG. 41 Europe ADHD market, 2014 - 2025 (USD Million)
FIG. 42 U.K. ADHD market, 2014 - 2025 (USD Million)
FIG. 43 Germany ADHD market, 2014 - 2025 (USD Million)
FIG. 44 France ADHD market, 2014 - 2025 (USD Million)
FIG. 45 Asia Pacific ADHD market, 2014 - 2025 (USD Million)
FIG. 46 Japan ADHD market, 2014 - 2025 (USD Million)
FIG. 47 China ADHD Market, 2014 - 2025 (USD Million)
FIG. 48 Latin America ADHD market, 2014 - 2025 (USD Million)
FIG. 49 Brazil ADHD market, 2014 - 2025 (USD Million)
FIG. 50 Mexico ADHD market, 2014 - 2025 (USD Million)
FIG. 51 MEA ADHD market, 2014 - 2025 (USD Million)
FIG. 52 South Africa ADHD market, 2014 - 2025 (USD Million)
FIG. 53 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.